BPC-157
Who holds supplier records for BPC-157? 2 organisations hold a current record for BPC-157: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: China (2).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “BPC-157: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/bpc-157
Reading the evidence
- 2 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in China
2 of the 2 current records with a recorded country list China. Organisation country is not necessarily the manufacturing site.
- 1 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (2)
Organisations holding an active US FDA Type II Drug Master File or a CEP for BPC-157. Country is the organisation's recorded country, not necessarily the manufacturing site.
- GUIZHOU UTIDE BIOTECHNOLOGY CO LTDChinaActive DMF 44617, 44629 · latest filing Sept 2026
- Hybio Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 44673 · latest filing Aug 2026
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Overview
BPC-157 is a protein active pharmaceutical ingredient (ChEMBL CHEMBL4297358).
Chemical identity
- IUPAC name
- (4S)-4-[(2-aminoacetyl)amino]-5-[(2S)-2-[(2S)-2-[(2S)-2-[[2-[[(2S)-6-amino-1-[(2S)-2-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[2-[[(2S)-1-[[(1S)-1-carboxy-2-methylpropyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-2-oxoethyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-5-oxopentanoic acid
- Canonical SMILES
- C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@@H]3CCCN3C(=O)[C@@H]4CCCN4C(=O)[C@H](CCC(=O)O)NC(=O)CN
- InChIKey
- HEEWEZGQMLZMFE-RKGINYAYSA-N
- Synonyms
- Bepecin, Bpc-157, PL-10, PL-14736, PLD-116, Bpc 157, Bpc 15, RefChem:121176, Bpc157, Booly protection compound 15, BPC-157 free base, BPC 157 trifluoroacetate
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for BPC-157?
2 organisations hold an active US FDA Type II Drug Master File or a CEP for BPC-157: GUIZHOU UTIDE BIOTECHNOLOGY CO LTD (China) and Hybio Pharmaceutical Co., Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which BPC-157 Drug Master Files are active?
GUIZHOU UTIDE BIOTECHNOLOGY CO LTD (DMF 44617, 44629) and Hybio Pharmaceutical Co., Ltd. (DMF 44673). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
How do I qualify a BPC-157 supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply BPC-157?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.